Use of polypeptides of cupredoxin family in cancertherapy.

Cytotoxic factors having use in modulating cell death, and their use in methods of treating necrosis or apoptosis-related conditions are disclosed. The invention also relates to methods for identifying active agents useful in treating conditions related to cell death or uncontrolled growth. The present inventors have found that different microorganisms produce different cylotoxic factor(s) having anticancer activity. The substantially pure cytotoxic factors can be used in a method of treating an infectious disease or a cancer.

Patents:
QA 13,308

Inventor(s): CHAKRABARTY ANANDA M [US]; DAS GUPTA TAPAS K [US]; HIRAOKA YOSHINORI [US]; PUNJ VASU [US]; YAMADA TOHRU [US]; ZABORINA OLGA [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent